Renovacor

Philadelphia, United States

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

$30.0M raised

Sep 2021

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Renovacor raised?

Renovacor has raised $30.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2021.

Who are Renovacor's investors?

Renovacor's investors include RTW Investments, BioAdvance, New Leaf Venture Partners, Acorn Bioventures, Novartis Venture Fund.

Where is Renovacor headquartered?

Renovacor is headquartered in Philadelphia, United States.

What does Renovacor do?

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

What stage is Renovacor at?

Renovacor is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 3, 2021.

MLA

"Renovacor — Funding & Investors." VCBacked, September 3, 2021, https://www.vcbacked.co/company/renovacor. Accessed July 2, 2026.

APA

VCBacked. (2021). Renovacor — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/renovacor

Wikipedia (cite web)

{{cite web |title=Renovacor — Funding & Investors |url=https://www.vcbacked.co/company/renovacor |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 3, 2021.